The Prevention Paradox

From the Editor
Glaucoma treatment asks patients, physicians, and payers to act before the consequences are visible.

By: Nathan Radcliffe, MD

Glaucoma Physician September 1, 2026 Page(s): 4

Clinical Report: The Prevention Paradox

Background

Glaucoma is a leading cause of irreversible blindness, and its management often requires long-term commitment from patients. Understanding the dynamics between patient behavior and treatment adherence is crucial for improving glaucoma care.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

Glaucoma treatment often feels repetitive, with many follow-up visits resulting in similar discussions about medication adherence.
Patients may not recognize the importance of daily treatment to preserve their vision over the long term.
Payers may resist early intervention due to immediate costs.
Innovative treatment options, such as laser therapy and sustained drug delivery, aim to improve patient adherence and outcomes.
Successful glaucoma management often means preventing deterioration rather than improving current vision.

Clinical Implications

Healthcare professionals should emphasize the importance of early intervention in glaucoma treatment to patients. Additionally, advocating for better reimbursement policies may enhance patient access to necessary treatments.

Conclusion

Addressing the prevention paradox in glaucoma care requires a concerted effort from both clinicians and payers to prioritize early intervention and patient education.